The estimated Net Worth of Spacavazza Paolo Leadiant B... is at least $1.01 Milion dollars as of 29 November 2017. Spacavazza B owns over 293,510 units of Soligenix Inc stock worth over $1,009,674 and over the last 7 years Spacavazza sold SNGX stock worth over $0.
Spacavazza has made over 1 trades of the Soligenix Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Spacavazza bought 293,510 units of SNGX stock worth $622,241 on 29 November 2017.
The largest trade Spacavazza's ever made was buying 293,510 units of Soligenix Inc stock on 29 November 2017 worth over $622,241. On average, Spacavazza trades about 293,510 units every 0 days since 2017. As of 29 November 2017 Spacavazza still owns at least 293,510 units of Soligenix Inc stock.
You can see the complete history of Spacavazza B stock trades at the bottom of the page.
Over the last 15 years, insiders at Soligenix Inc have traded over $502,220 worth of Soligenix Inc stock and bought 775,279 units worth $1,096,136 . The most active insiders traders include Randal Jintrexon Corp Kirk, Jerome B Zeldis oraz Spacavazza Paolo Leadiant B.... On average, Soligenix Inc executives and independent directors trade stock every 115 days with the average trade being worth of $91,349. The most recent stock trade was executed by Richard Straube on 18 May 2022, trading 8,000 units of SNGX stock currently worth $4,000.
soligenix, inc. is a late stage biopharmaceutical company committed to developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense. soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as cutaneous t-cell lymphoma, oral mucositis, pediatric crohn's disease, acute radiation enteritis, and 2) a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis.
Soligenix Inc executives and other stock owners filed with the SEC include: